Jaguar Health (JAGX) Amortization of Deferred Charges (2014 - 2024)

Jaguar Health (JAGX) has 10 years of Amortization of Deferred Charges data on file, last reported at $274000.0 in Q1 2024.

• Amortization of Deferred Charges for Q1 2024 came in at $274000.0, down 78.53% year-over-year; the trailing twelve-month figure through Dec 2024 was $274000.0 (down 97.93% YoY), and the FY2025 annual result was $153000.0, down 44.16% from the prior year.
• Amortization of Deferred Charges retreated to $274000.0 in Q1 2024 per JAGX's latest filing, from $1.7 million in the prior quarter.
• Over five years, Amortization of Deferred Charges peaked at $7.1 million in Q3 2023 and troughed at $174000.0 in Q2 2020.
• A 5-year average of $1.9 million and a median of $1.5 million in 2021 frame the typical range for Amortization of Deferred Charges.
• The sharpest annual moves came in 2020 and 2021: Amortization of Deferred Charges plunged 95.45% in 2020, then jumped 608.62% in 2021.
• A 5-year view of Amortization of Deferred Charges shows it stood at $2.0 million in 2020, then decreased by 22.21% to $1.5 million in 2021, then soared by 92.91% to $3.0 million in 2022, then sank by 42.37% to $1.7 million in 2023, then plunged by 83.98% to $274000.0 in 2024.
• Business Quant data shows JAGX's Amortization of Deferred Charges at $274000.0 in Q1 2024, $1.7 million in Q4 2023, and $7.1 million in Q3 2023.